by Jonathan Benson, staff writer
(NaturalNews) The long-term health damage caused by the great H1N1 swine flu scam “pandemic” of 2009 — and particularly the mass vaccination campaign that accompanied it — is already becoming apparent in the form of an autoimmune disorder. A new review published in the journal Public Library of Science ONE confirms that Pandemrix, a swine flu vaccine produced by drug giant GlaxoSmithKline (GSK), is responsible for causing an up to 1700 percent increase in narcolepsy among children and teenagers under 17 years of age.
Based on their findings, a cohort of scientists has determined that narcolepsy rates increased significantly following mass vaccination campaigns with Pandemrix. Compiled data has revealed that between 2002 and 2009, the narcolepsy rate among children under age 17 was 0.31 per 100,000. But in 2010, that number jumped to 5.3 per 100,000, which represents a 17-fold increase.
Similarly, research compiled by Markku Partinen of the Helsinki Sleep Clinic and Hanna Nohynek of the National Institute for Health and Welfare in Finland, both of which were also involved in the new research, has determined a link between Pandemrix and narcolepsy. Children not vaccinated with Pandemrix were found to have a 1300 percent less risk of developing narcolepsy compared to children who were vaccinated with Pandemrix.
But because the subject of controversy is a vaccine, researchers were quick to inject several caveats to their findings that deflected some of the blame to other potential causes. In their soft-peddled, politically-correct conclusion, researchers said they “consider it likely that Pandemrix vaccination contributed, perhaps together with other environmental factors, to this increase in genetically susceptible children.”
But the findings are strong enough to have prompted officials in Great Britain to begin their own investigation into Pandemrix causing narcolepsy in children. Though the U.K.’s Health Protection Agency (HPA) has declared that seasonal flu vaccine is not linked to narcolepsy, the agency is concerned that Pandemrix is of a different breed, and that it is not necessarily safe for children (http://www.guardian.co.uk).
Back in 2009, it was confirmed that narcolepsy is actually an autoimmune disorder characterized by missing brain cells that are responsible for producing hypocretin, a hormone that promotes wakefulness. Based on those findings, which were published in the journal Nature Genetics, it appears as though Pandemrix may be responsible for actually spurring the immune system to destroy vital hormone-producing cells in young children (http://www.sciencedaily.com/releases/2009/05/090503132613.htm).
Sources for this article include: